Chinese Medicine Treat for Hypertensive Renal Injury
Status:
Not yet recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
This study evaluates whether the traditional chinese medicine (Qianyangyuyin formula) could
prevent and treat early renal injury in patients with hypertension and microalbuminuria
(defined as a urinary albumin to creatinine ratio between 30 and 300 mg/g) based on standard
antihypertensive treatment.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jiangsu Province Hospital of Traditional Chinese Medicine
Collaborators:
Ministry of Science and Technology of the People´s Republic of China The affiliated hospital of Liaoning University of Traditional Chinese Medicine The First Affiliated Hospital of Henan University of Traditional Chinese Medicine